We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AVRO market cap is 62.85M. The company's latest EPS is USD 0.2762 and P/E is 185.30.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -15.73M | -22.93M | -9.66M | -7.94M | -16.45M |
Net Income | 67.48M | -21.58M | -8.54M | -6.81M | -21.08M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -75.81M | -120.23M | -118.84M | -105.43M | -73.54M |
Net Income | -72.97M | -119.71M | -119.13M | -105.89M | 12.4M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 133.84M | 110.52M | 101.09M | 92.35M | 193.91M |
Total Liabilities | 11.8M | 7.66M | 6.35M | 3.51M | 27.54M |
Total Equity | 122.04M | 102.86M | 94.74M | 88.84M | 166.37M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 200.51M | 271.23M | 203.84M | 103.95M | 101.09M |
Total Liabilities | 14.5M | 16.89M | 34.36M | 28.58M | 6.35M |
Total Equity | 186.01M | 254.34M | 169.48M | 75.37M | 94.74M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -34.94M | -55.16M | -63.19M | -7.57M | -22.66M |
Investing | 83.73M | 84.93M | 85.08M | N/A | N/A |
Financing | -16.27M | -16.09M | -16.03M | 30k | 179.07M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -67.67M | -98.8M | -98.03M | -97.21M | -63.19M |
Investing | -1.59M | -1.18M | -2.46M | -267k | 85.08M |
Financing | 129.99M | 172.62M | 30.37M | 262k | -16.03M |
Market Cap | 62.85M |
Price to Earnings Ratio | 185.30 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 23.44 |
Price to Book Ratio | 24.25 |
Dividend Yield | - |
Shares Outstanding | 44.89M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.07 (4.79%) |
Company Name | AVROBIO Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://tectonictx.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions